Series A · BiotechThink Bioscience: Series ADevelops small molecule drugs for historically challenging drug targetsPublished Oct 4, 2026By RoundOS Funding deskFunding historyJan 20, 2026Series A · This round$55MSourcesprnewswire.com↗
Isomorphic LabsBuilds an AI-first drug design engine to accelerate discovery and development across multiple therapeutic areas$5BSeries C · Nov 17, 2026
Marrow TherapeuticsMarrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.$120MSeries B · Nov 17, 2026
Marrow TherapeuticsMarrow Therapeutics develops bone marrow-targeted genetic medicines for severe blood disorders.$53MSeries A financing disclosure · Nov 17, 2026
Science CorporationDevelops brain-computer interface retinal implants to restore vision in patients with retinal diseases$400MSeries D · Nov 17, 2026